Malaysia - English - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

merck sharp & dohme (malaysia) sdn bhd - letermovir -

New Zealand - English - Medsafe (Medicines Safety Authority)

merck sharp & dohme (new zealand) limited - letermovir 240mg - concentrate for infusion - active: letermovir 240mg excipient: hydroxypropyl-beta-cyclodextrin sodium chloride sodium hydroxide water for injection - prevymis is indicated for the prophylaxis of cytomegalovirus (cmv) infection or disease in adult cmv-seropositive recipients [r+] of an allogeneic hematopoietic stem cell transplant (hsct).

New Zealand - English - Medsafe (Medicines Safety Authority)

merck sharp & dohme (new zealand) limited - letermovir 480mg - concentrate for infusion - active: letermovir 480mg excipient: hydroxypropyl-beta-cyclodextrin sodium chloride sodium hydroxide water for injection - prevymis is indicated for the prophylaxis of cytomegalovirus (cmv) infection or disease in adult cmv-seropositive recipients [r+] of an allogeneic hematopoietic stem cell transplant (hsct).

New Zealand - English - Medsafe (Medicines Safety Authority)

merck sharp & dohme (new zealand) limited - letermovir 240mg - film coated tablet - 240 mg - active: letermovir 240mg excipient: carnauba wax colloidal silicon dioxide croscarmellose sodium magnesium stearate microcrystalline cellulose opadry yellow 39k120004 povidone as povidone 25 purified water - prevymis is indicated for the prophylaxis of cytomegalovirus (cmv) infection or disease in adult cmv-seropositive recipients [r+] of an allogeneic hematopoietic stem cell transplant (hsct).

New Zealand - English - Medsafe (Medicines Safety Authority)

merck sharp & dohme (new zealand) limited - letermovir 480mg - film coated tablet - 480 mg - active: letermovir 480mg excipient: carnauba wax colloidal silicon dioxide croscarmellose sodium magnesium stearate microcrystalline cellulose opadry pink 39k140009 povidone as povidone 25 purified water - prevymis is indicated for the prophylaxis of cytomegalovirus (cmv) infection or disease in adult cmv-seropositive recipients [r+] of an allogeneic hematopoietic stem cell transplant (hsct).